BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28419517)

  • 1. Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma.
    Cavalli M; De Novi LA; Della Starza I; Cappelli LV; Nunes V; Pulsoni A; Del Giudice I; Guarini A; Foà R
    Br J Haematol; 2017 May; 177(4):588-596. PubMed ID: 28419517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
    Della Starza I; Cavalli M; De Novi LA; Genuardi E; Mantoan B; Drandi D; Barbero D; Ciabatti E; Grassi S; Gazzola A; Mannu C; Agostinelli C; Piccaluga PP; Bomben R; Degan M; Gattei V; Guarini A; Foà R; Galimberti S; Ladetto M; Ferrero S; Del Giudice I;
    Hematol Oncol; 2019 Oct; 37(4):368-374. PubMed ID: 31325190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A real-time (PCR) for a real life…? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice.
    Janikova A; Mareckova A; Dvorakova D; Bortlicek Z; Tichy B; Navratil M; Kral Z; Pospisilova S; Mayer J
    Exp Hematol; 2012 Jul; 40(7):528-539.e4. PubMed ID: 22381682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
    Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
    Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum BCL2/IGH DNA in follicular lymphoma patients: a minimal residual disease marker.
    Gocke CD; Kopreski MS; Benko FA; Sternas L; Kwak LW
    Leuk Lymphoma; 2000 Sep; 39(1-2):165-72. PubMed ID: 10975396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
    Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy.
    Pulsoni A; Della Starza I; Cappelli LV; Tosti ME; Annechini G; Cavalli M; De Novi LA; D'Elia GM; Grapulin L; Guarini A; Del Giudice I; Foà R
    Br J Haematol; 2020 Jan; 188(2):249-258. PubMed ID: 31385309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.
    Voso MT; Hohaus S; Moos M; Haas R
    Blood; 1997 May; 89(10):3763-8. PubMed ID: 9160682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
    Drandi D; Kubiczkova-Besse L; Ferrero S; Dani N; Passera R; Mantoan B; Gambella M; Monitillo L; Saraci E; Ghione P; Genuardi E; Barbero D; Omedè P; Barberio D; Hajek R; Vitolo U; Palumbo A; Cortelazzo S; Boccadoro M; Inghirami G; Ladetto M
    J Mol Diagn; 2015 Nov; 17(6):652-60. PubMed ID: 26319783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources.
    Léonard BM; Hétu F; Busque L; Gyger M; Bélanger R; Perreault C; Roy DC
    Blood; 1998 Jan; 91(1):331-9. PubMed ID: 9414302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.
    Bowman A; Jones D; Medeiros LJ; Luthra R
    J Mol Diagn; 2004 Nov; 6(4):396-400. PubMed ID: 15507680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follicular lymphomas: molecular diagnosis using t(14;18)(q32;q21)--fluorescence in situ hybridization, qualitative and quantitative PCR].
    Mrhalová M; Krsková L; Kalinová M; Soukup J; Kodet R
    Cesk Patol; 2003 Jul; 39(3):130-7. PubMed ID: 14631811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders.
    Drandi D; Ferrero S; Ladetto M
    Methods Mol Biol; 2018; 1768():229-256. PubMed ID: 29717447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
    Pulsoni A; Starza ID; Frattarelli N; Ghia E; Carlotti E; Cavalieri E; Matturro A; Tempera S; Rambaldi A; Foà R
    Br J Haematol; 2007 May; 137(3):216-20. PubMed ID: 17408460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliable detection of clonal IgH/Bcl2 MBR rearrangement in follicular lymphoma: methodology and clinical significance.
    Iqbal S; Jenner MJ; Summers KE; Davies AJ; Matthews J; Norton AJ; Calaminici M; Rohatiner AZ; Fitzgibbon J; Lister TA; Goff LK
    Br J Haematol; 2004 Feb; 124(3):325-8. PubMed ID: 14717779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.
    Rambaldi A; Carlotti E; Oldani E; Della Starza I; Baccarani M; Cortelazzo S; Lauria F; Arcaini L; Morra E; Pulsoni A; Rigacci L; Rupolo M; Zaja F; Zinzani PL; Barbui T; Foa R
    Blood; 2005 May; 105(9):3428-33. PubMed ID: 15637137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
    Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
    J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
    Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.